Satellite Banner
Technology Networks Header
Friday, July 25, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Bowel Cancer Breakthrough May Benefit Thousands of Patients
Researchers at Queen’s University have discovered how two genes cause bowel cancer cells to become resistant to treatments used against the disease.
Study Finds Low Oxygen Environment Helps Tumors Silence Critical Genes
The study led by Yale Cancer Center may provide clues to how some aggressive cancers turn off, or silence, genes critical to suppressing tumors.
Researchers Uncover New Cancer Cell Vulnerability
The research showed that telomerase-expressing cells depend upon a gene named p21 for their survival.
Self-assembling Nanoparticle Could Improve MRI Scanning for Cancer Diagnosis
Scientists have designed the nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
Wisconsin Scientists Find Genetic Recipe to Turn Stem Cells to Blood
The ability to reliably and safely make in the laboratory all of the different types of cells in human blood is one key step closer to reality.
Capturing Cancer: A Powerful New Technique for Early Diagnosis
Researchers describe an innovative technique for early disease detection, which they call immunosignaturing.
Study Identifies Novel Genomic Changes in the Most Common Type of Lung Cancer
TCGA finds mutations in a key cancer-causing pathway, expanding targets for existing drugs.
Low Doses of Arsenic Cause Cancer in Male Mice
NIH researchers found that arsenic in drinking water develop lung cancer.
Brain Tumor Invasion Along Blood Vessels May Lead to New Cancer Treatments
NIH-funded researchers find brain tumor cells disrupt the brain’s protective barrier, offering potential avenues for therapy.
Revealing the Role of “Precocious” Dendritic Cells in Inflammatory Response
Discovery makes it possible for researchers to explore how these “precocious” cells escalate the body’s immune response when the body is under attack.
Scroll Up
Scroll Down
Return
Formulations for Using Dicer-Substrate siRNA in vivo
Mark Behlke, Vice President, Molecular Genetics, Integrated DNA Technologies, speaking at RNAi Europe 2007
Date Posted: Thursday, February 21, 2008
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



IDT Acquires SURVEYOR® Nuclease Business from Transgenomic
Addition of SURVEYOR enzyme and kits expands IDT's molecular biology product offerings.
Wednesday, July 02, 2014
Providing a Rapid and Reliable Method of Gene Cloning
Integrated DNA Technologies will be speaking at the upcoming Antibody Engineering and Therapeutics conference.
Monday, December 02, 2013
Webinar: the Cutting-edge qPCR Approach to Single-cell Expression Profiling
Join IDT and Professor Mikael Kubista for insight into pioneering qPCR methods, June 25.
Monday, June 24, 2013
IDT Launches Michael Zuker’s UNAFold Page
UNAFold secondary structure prediction software to be used to accurately detect secondary structures within sequences submitted by customers.
Thursday, December 02, 2010
IDT Presents at Presidential Commission for the Study of Bioethical Issues
Representing the International Gene Synthesis Consortium and its ongoing work to prevent the misuse of synthetic genes.
Tuesday, September 21, 2010
IDT is Awarded Further Funding for Gene Silencing Research
Company receives a Phase II SIBR grant to fund the ongoing ‘Gene Silencing with U1 Adapter Oligonucleotides’ research project.
Thursday, July 22, 2010
IDT Earns ISO 9001:2008 Certification at its European Oligonucleotide Production Headquarters
Worldwide certification of quality systems at all manufacturing operations completed.
Tuesday, April 27, 2010
Integrated DNA Technologies and Glycon Partner in Australia
Glycon will offer Australia’s scientists local sales and technical support of IDT’s products, complementing IDT’s existing global customer care network.
Monday, April 19, 2010
IDT Secures Funding for new Gene Silencing Research
IDT has been awarded $99,750 from NIH to continue work on its ‘Gene Silencing with U1 Adapter Oligonucleotides’ research project.
Monday, September 07, 2009
Major International Conferences to Hear About the Risks and Rewards of Synthetic Biology
IDT will be presenting recent developments in RNAi research, at Analytica and the RNAi World Congress.
Wednesday, March 19, 2008
IDT Acquires Belgian Manufacturer RNA-TEC
Purchase expands IDT's large-scale RNA synthesis capabilities; builds presence in European markets.
Tuesday, September 19, 2006
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv